Publications by authors named "Vojtech Parrak"

Claim this Profile
P
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217.
Branislav Kovacech, Nicholas C Cullen, Petr Novak, Jozef Hanes, Eva Kontsekova, Vojtech Parrak

Alzheimers Res Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Modern Therapeutic Drug Monitoring and Lipidomics Approaches in Clinical Practice: A Case Study with Colistin Treatment.
Ivana Gerhardtova, Ivana Cizmarova, Timotej Jankech, Dominika Olesova, Josef Jampilek, Vojtech Parrak

Pharmaceuticals (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple and green capillary electrophoresis-mass spectrometry method for therapeutic drug monitoring of colistin in clinical plasma samples.
Ivana Cizmarova, Vojtech Parrak, Peter Secnik, Peter Secnik, Ladislav Sopko

Heliyon· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Determination of 4 β-Lactam Antibiotics, Tazobactam, and Linezolid in Human Plasma Samples.
Juraj Piestansky, Ivana Cizmarova, Peter Mikus, Vojtech Parrak, Pavel Babiak

Ther Drug Monit· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern.
Branislav Kovacech, Lubica Fialova, Peter Filipcik, Rostislav Skrabana, Monika Zilkova, Vojtech Parrak

EBioMedicine· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease.
Petr Novak, Branislav Kovacech, Stanislav Katina, Reinhold Schmidt, Philip Scheltens, Vojtech Parrak

Nat Aging· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capillary electrophoresis and ultra-high-performance liquid chromatography methods in clinical monitoring of creatinine in human urine: A comparative study.
Juraj Piestansky, Jaroslav Galba, Branislav Kovacech, Vojtech Parrak, Andrej Kovac

Biomed Chromatogr· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling of Amino Acids in Urine Samples of Patients Suffering from Inflammatory Bowel Disease by Capillary Electrophoresis-Mass Spectrometry.
Juraj Piestansky, Dominika Olesova, Jaroslav Galba, Katarina Marakova, Vojtech Parrak

Molecules· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease.
Petr Novak, Reinhold Schmidt, Eva Kontsekova, Branislav Kovacech, Tomas Smolek, Vojtech Parrak

Alzheimers Res Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial.
Petr Novak, Reinhold Schmidt, Eva Kontsekova, Norbert Zilka, Branislav Kovacech, Vojtech Parrak

Lancet Neurol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical Huntington's disease with the clinical presentation of behavioural variant of frontotemporal dementia.
Stanislav Sutovsky, Tomas Smolek, Irina Alafuzoff, Andrej Blaho, Vojtech Parrak

J Neural Transm (Vienna)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detection.
Jaroslav Galba, Alena Michalicova, Vojtech Parrak, Michal Novak, Andrej Kovac

J Pharm Biomed Anal· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced glycation end products in myocardial reperfusion injury.
Peter Celec, Július Hodosy, Peter Jáni, Pavol Janega, Matúš Kúdela

Heart Vessels· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians.
Katarína Sebeková, Peter Boor, Martina Valachovicová, Pavol Blazícek, Vojtech Parrák

Mol Nutr Food Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional hyperhomocysteinemia in healthy vegetarians: no association with advanced glycation end products, markers of protein oxidation, or lipid peroxidation after correction with vitamin B(12).
Katarína Sebeková, Marica Krajcovicová-Kudlácková, Pavol Blazícek, Vojtech Parrák, Reinhard Schinzel

Clin Chem· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis